Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:45 PM
Ignite Modification Date:
2025-12-24 @ 3:45 PM
NCT ID:
NCT00677092
Eligibility Criteria:
Inclusion Criteria:
* Age \> 18 years
* Biopsy-proven NSF
* Ability to give consent
Exclusion Criteria:
* Known sensitivity to imatinib mesylate or to any of its components
* Pregnant or lactating woman
* Bullous dermatologic disease
* Aspartate aminotransferase / alanine aminotransferase (AST/ALT) \>3 x upper limit of normal
* Severe congestive heart failure \[New York Heart Association (NYHA) Class III or IV\]
* Patients who have received Gleevec in the past 12 months
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00677092
Study Brief:
Protocol Section:
NCT00677092